Clinical Trial 38751


Long Beach, CA 90806

Study Summary:

This is a phase 2 study to compare the efficacy and safety of treatment with SUVN-502 to placebo treatment in subjects with moderate Alzheimer's disease receiving donepezil HCl (10 mg qd) and either memantine HCl (10 mg twice daily [bid]) or Namenda XR® (28 mg qd) or the combination therapy, Namzaric™.

Qualified Participants Must:

• Qualified participants must be 50 to 85 years old and have Alzheimer's symptoms.

Qualified Participants May Receive:

Compensation for time and travel, participants may receive investigational medication or placebo.

Study is Available At:

2600 Redondo Ave
Long Beach, CA 90806
View Clinic Location


If you or someone you care for is interested in participating in this clinical trial and lives within 50 miles of the clinic, please complete the form below and click 'I Am Interested In This Study'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.